These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 18043882)
1. Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels. Jarai R; Iordanova N; Jarai R; Jarai F; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K Wien Klin Wochenschr; 2007; 119(21-22):626-32. PubMed ID: 18043882 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores. Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547 [TBL] [Abstract][Full Text] [Related]
3. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome. Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247 [TBL] [Abstract][Full Text] [Related]
4. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study. He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes. Manenti ER; Bodanese LC; Camey SA; Polanczyk CA Clin Cardiol; 2006 Sep; 29(9):405-10. PubMed ID: 17007172 [TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide. Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706 [TBL] [Abstract][Full Text] [Related]
7. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome]. Liu WX; Zhao H Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085 [TBL] [Abstract][Full Text] [Related]
8. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome. Castro LR; Alencar MC; Barbosa MM; Nunes Mdo C; Cardoso JR; Ribeiro AL Arq Bras Cardiol; 2011 Dec; 97(6):456-61. PubMed ID: 22030563 [TBL] [Abstract][Full Text] [Related]
9. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial. Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ; Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879 [TBL] [Abstract][Full Text] [Related]
10. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes? Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352 [TBL] [Abstract][Full Text] [Related]
11. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes. Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087 [TBL] [Abstract][Full Text] [Related]
12. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery. Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704 [TBL] [Abstract][Full Text] [Related]
13. Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention. Pan R Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255302 [TBL] [Abstract][Full Text] [Related]
14. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657 [TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related]
17. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score. Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055 [TBL] [Abstract][Full Text] [Related]
18. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome. Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492 [TBL] [Abstract][Full Text] [Related]
19. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score. Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283 [TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II). Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]